Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
about
Role of imaging techniques in the diagnosis of dementia18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)What we need to know about age related memory lossAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersClinical molecular imaging with radiotracers: current statusPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsBrain PET in the diagnosis of Alzheimer's diseaseUshering in the study and treatment of preclinical Alzheimer diseaseFluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatmentsChronic adjunction of 1-deoxynojirimycin protects from age-related behavioral and biochemical changes in the SAMP8 mice.Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementiaNeuroimaging of individuals with Down’s syndrome at-risk for dementia: Evidence for possible compensatory eventsNeuronuclear imaging in the evaluation of dementia and mild decline in cognition.Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.Imaging amyloid-beta deposits in vivo.Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology.What have novel imaging techniques revealed about metabolism in the aging brain?Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.The role of biomarkers in clinical trials for Alzheimer diseaseMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease.Linking brain imaging and genomics in the study of Alzheimer's disease and aging.Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.Imaging biomarkers and their role in dementia clinical trials.Diagnostic imaging devices in Alzheimer's disease.Biomarkers for early detection of Alzheimer pathology.Current and future uses of neuroimaging for cognitively impaired patients.Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer's diseaseAltered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC.Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.Adjustment for selection bias in observational studies with application to the analysis of autopsy dataInitial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer diseaseAdvances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.Biomarkers in translational research of Alzheimer's diseaseCurrent Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.
P2860
Q22241579-AB7ED175-7366-4609-B3A4-0EC1B932C135Q24186399-C4E7003A-4020-4096-BB5C-D65BF1A0A222Q24527203-6F70F79B-D10E-449A-8EBD-BA4F2126DEA1Q26825442-C8462D2C-4639-41B6-B6CF-A23FFD6BF2DAQ26994741-CF9758C0-E168-4D76-A48F-2AE18B0E69EDQ26995405-4FC269FB-57E6-414F-87A0-B83B8DDD1170Q27011549-40C99CE9-A8D8-4098-87BD-56DE4E39CDD1Q27014791-42C095B3-6C25-47DD-9674-107BA0D61B3DQ27024117-A398233D-FBC1-4B15-9489-0E8E78338FF6Q27313788-BCE9A569-1EE2-4AC2-9FB8-2DF9BDF0FEA6Q29397661-580481AD-0096-42AB-BDB6-DF8D36108729Q30051683-2130D01E-A634-40F2-8B30-EBF837C2EDF8Q30571571-7E41C551-47D3-4F8F-BE71-C8C398DF46FFQ30597616-BD9E658F-94D1-4843-B0B8-9AA1D8488066Q30720928-C471FA88-B879-4827-8326-5610B9815F82Q30756562-2A327C61-0917-4FD1-B154-75E010C676B0Q30850844-19398A4A-08D2-4C8F-9D06-32FCC4A1AA80Q30945416-B04F74CB-F55F-4FC5-9EA6-1D84D6D8F0FCQ30988163-18F344AF-AFAC-474A-ADEC-617786465384Q30989943-BE02E588-CCFB-4E53-B986-6138119C6F95Q31032781-F6DDD86D-1CF1-4872-8A00-DD23060A7F7FQ31047131-B96F673E-B7B9-4D9C-864F-70043C44FEB3Q31050735-CB8DE82C-D1C3-45C7-BFF3-C9F50292A9BAQ31108276-F6CB5E46-3734-481B-A5A2-4BC0D7E03C9BQ31108280-A9284BAC-7F5D-4841-B5A8-D866C5FBFABCQ31108283-D7A73E3C-D553-4359-B4EB-FA1CAF09F0ECQ31110945-C30653F7-75FA-45D7-91FE-573982BCBA09Q31117394-5E606CAF-DC49-4A7C-B80C-6E7F8BEF8F22Q31140680-22A362D7-342F-48C2-8209-19CEE1EA1ACAQ31143267-DB594CF5-0358-442C-AC08-E90CD172883EQ31143998-AE0F6888-FA1A-4856-9688-F25B4896C865Q31146509-B17B0F1F-F934-43DC-9882-3478B8209077Q31153910-497E953E-3188-40A1-ADB9-2ECACCF12BBEQ33194112-E155CFE7-F5A0-464B-9CA2-B0E8AB58C46CQ33202814-D04C6C67-08BE-4883-98DD-9471B322E290Q33403727-9138DB26-1094-473D-A377-8B3348D52E95Q33523947-24C48AB9-9884-4ED0-A302-D2DEF32D1BE2Q33526779-88C1753F-6029-4A3A-ACB9-89AE23C748BCQ33556189-83C9A8D4-D7BD-4082-81FF-322C3D3505ABQ33590723-0521E593-3DBF-40A6-9CBB-7F02536FE335
P2860
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Positron emission tomography i ...... abolism and long-term outcome.
@en
Positron emission tomography i ...... abolism and long-term outcome.
@nl
type
label
Positron emission tomography i ...... abolism and long-term outcome.
@en
Positron emission tomography i ...... abolism and long-term outcome.
@nl
prefLabel
Positron emission tomography i ...... abolism and long-term outcome.
@en
Positron emission tomography i ...... abolism and long-term outcome.
@nl
P2093
P356
P1476
Positron emission tomography i ...... abolism and long-term outcome.
@en
P2093
A P Kowell
D H Silverman
G E Alexander
P304
P356
10.1001/JAMA.286.17.2120
P407
P577
2001-11-01T00:00:00Z